)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals (EPRX) investor relations material
Eupraxia Pharmaceuticals Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary11 Aug, 2026
Executive summary
Presented new data at Digestive Disease Week showing improvement in fibrosis and inflammation after a single EP-104GI treatment in EoE patients.
Strengthened executive team and board with key appointments to support late-stage drug development and commercialization.
Transitioned to a two-hub organization in Vancouver and Seattle, with leadership changes in technical operations and R&D.
Financial highlights
Reported net loss of $14.5 million for Q2 2026, compared to $8.7 million in Q2 2025, mainly due to increased R&D and administrative costs.
Cash and cash equivalents of $52.4 million and short-term investments of $81.2 million as of June 30, 2026, up from $80.6 million at the end of Q4 2025.
Existing cash reserves expected to fund operations into the second half of 2028.
Outlook and guidance
Interim data from the Phase 2b EoE trial expected in Q4 2026, with Phase 3 trial initiation and expansion of EP-104GI indications planned for 2027.
Anticipates continued progress in late-stage development and commercialization of EP-104GI.
Explain the dose-response in EREFS findings
Explain the impact of RESOLVE Part 2 on R&D costs
Explain the Vancouver and Seattle hub transition
Compare EP-104GI vs EP-104IAR H1 2026 costs
Detail Auritec milestone and monetization terms
Explain the Preferred Share dividend structure
Rationale for pausing EP-104IAR development
Drug release mechanism of Diffusphere technology
Auritec license milestone payment schedule
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Eupraxia Pharmaceuticals
- EP-104GI single-dose injection yields sustained, dose-dependent histological improvement in EoE.EPRX
Investor presentation - EP-104GI offers increased revenue for GI practices with minimal workflow disruption.EPRXInvestor presentation
- EP-104GI demonstrated safety and sustained efficacy in reducing EoE inflammation and dysphagia.EPRXInvestor presentation
- Registering up to US$300M in securities to fund late-stage drug development for EoE and OA.EPRXRegistration filing
- Long-acting injectable for EoE achieves 80% remission at six months, with expansion into GI diseases.EPRXJefferies Global Healthcare Conference 2026
- Rapid, durable EoE remission and pipeline expansion position for major GI market impact.EPRXBloom Burton & Co. Healthcare Investor Conference 2026
- Strong clinical progress and financial position set the stage for major growth in EoE treatment.EPRXCorporate presentation
- Strong clinical progress and improved financials position the company for continued growth.EPRXQ2 2024
- Advanced clinical trials and secured funding to support operations through Q3 2026.EPRXQ3 2024
Next Eupraxia Pharmaceuticals earnings date
Q3 20263 Nov, 2026
Eupraxia Pharmaceuticals
Next Eupraxia Pharmaceuticals earnings date
Q3 20263 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage